Antineoplastic drug-use process at a rural hospital.
This article describes the antineoplastic drug-use process and monitoring activities performed by the Department of Pharmacy at a 225-bed rural hospital. Documents developed and used in the process assist the pharmacist in assessing drug-related toxicity, in making recommendations for laboratory or system studies, and for organizing a therapeutic rationale for inpatients and out-patients. Involvement of pharmacists in oncology in rural or small institutions can be essential for maximal therapeutic monitoring and quality patient care. The importance of monitoring antineoplastics on a per patient basis is highlighted.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination / Q000592:standards*; D006744:Hospital Bed Capacity, 100 to 299; D006801:Humans; D009820:Ohio; D010607:Pharmacy Service, Hospital / Q000458:organization & administration*; D011785:Quality Assurance, Health Care; D012424:Rural Population